Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Leucosceptoside A shows inhibitory activity against PKCalpha with the IC50 value of 19.0 microM; it also exhibits strong inhibitory capacity against α-glucosidase. Leucosceptoside A has antihypertensive effect, it shows angiotensin converting enzyme (ACE) inhibitory effect in a dose-dependent manner of which IC(50) value of 423+/-18.8 microg/ml.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 698.00 | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 940.00 |
Description | Leucosceptoside A shows inhibitory activity against PKCalpha with the IC50 value of 19.0 microM; it also exhibits strong inhibitory capacity against α-glucosidase. Leucosceptoside A has antihypertensive effect, it shows angiotensin converting enzyme (ACE) inhibitory effect in a dose-dependent manner of which IC(50) value of 423+/-18.8 microg/ml. |
Targets&IC50 | PKCα:19 μM (IC50) |
Source |
Molecular Weight | 638.619 |
Formula | C30H38O15 |
CAS No. | 83529-62-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Leucosceptoside A 83529-62-8 Chromatin/Epigenetic Cytoskeletal Signaling Endocrinology/Hormones RAAS PKC inhibitor inhibit